A new study is advancing the understanding of lupus nephritis, (LN, lupus-related kidney disease), identifying a ...

In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...

People living with lupus develop strengths that are unique to this journey, and it’s time we paused to honor and celebrate the strengths of a lupus warrior.

National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...

If you have a parent, sibling, or child diagnosed with lupus — but you do not have lupus yourself — you may be eligible to participate in CARE Lupus. Lupus has long been treated after symptoms begin - ...

The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...

The Lupus Foundation of America’s (LFA) Community Health Worker (CHW) hub was created to increase awareness of lupus and knowledge of resources available. The CHW hub features on-demand learning ...

May is Lupus Awareness Month! Rally your family, friends and community to raise funds and awareness of the invisible physical, emotional and financial impact of lupus. Help us continue to advocate, ...

This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...

People with lupus can have cognitive symptoms, like having a hard time thinking clearly or remembering things. This is also called “brain fog” or “lupus fog,” and it often comes and goes over time. In ...